RankAlpha logo
Back to Rankings

KTTA

Pasithea TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
KTTA vs peer average
93/100
KTTA vs. peer average (A vs. D)
Grade spread
A 1 · B 2 · C 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

BOLD is the first available peer comparator.

Another packet-supplied small-cap biotech candidate near KTTA's market-cap range; it is best treated as a market-cap and capital-markets comp, with limited value for program-level read-through.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBOLDBoundless Bio
KTTA
Pasithea Therapeutics
BOLD
Boundless Bio
Grade
A
C
Momentum
83
40
Value
42
57
Sentiment
70
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs BOLD

KTTA / BOLD
Grade Position
Above peers
KTTA vs. peer average (A vs. D)
93/100
Momentum
83
KTTA
Value
42
BOLD
Sentiment
70
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs KTTA
1
BOLD
BOLD
C
60/100
+2
2
NRSN
NRSN
F
20/100
+4
3
BCTX
BriaCell Therapeutics Corp Common
F
20/100
+4
4
CLRB
Cellectar Biosciences Inc Common
B
80/100
+1
5
LGVN
Longeveron Inc Class A Common
F
20/100
+4
BOLD is the first peer returned for this comparison set.